World Hepatitis Day
With 1 person dying every 30 seconds due to hepatitis related illness, the importance of controlling and curbing the spread of this deadly disease has never been as important since its onset in the 17th century.
The 5 mainly identified types of hepatitis are: A, B, C, D, and E, although we are currently experiencing and unexplained a new outbreak of acute hepatitis infections affecting children. The new outbreak that does not belong to any of the 5 above mentioned categories are currently being extensively studied in the respective regions of outbreak. Although many of these infections show only mild symptoms and go undetected but, in some cases, can prove fatal. The death toll due to hepatitis A through E globally surpassed 75,000 per annum for the past 3 years. Global estimates say that only 16% of the worlds hepatitis B infection has been diagnosed and 25 % for hepatitis C and less than 10 % are receiving adequate treatment.
Along with the global efforts along to curb the spread of acute hepatitis infections the priority is also taken to completely eradicate B, C and D Infections which causes chronic hepatitis, lasting over decades which reflect in over 1 million deaths due to liver cirrhosis and liver cancer.
People centric alignment of systems and integration is crucial to reach a goal of at least 60 % of total diagnosis of hepatitis infection and 50 % treatment of hepatitis related infections by 2025. We the general public can help with this mission by keeping in mind a few simple precautions:
1. Use sterile injections always
2. Use your own razors and blades
3. Practise safe sex
4. Use safe tattooing and piercing equipment
5. Vaccinate infants against Hepatitis B
ProTip: Recognizing the year’s theme of bringing hepatitis care closer to you, the first step and most crucial step is to get tested. Promea’s ELISA and rapid based hepatitis testing kits have been validated and confirmed by leading plasma collection facilities and are fully equipped to provide the quality and speed of testing required to achieve WHO’s goal of diagnosis of infections by 2025.